CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Novartis CEO says latest China deals are just following the science

EarningsNeutral
AI Analysis

Summary

Novartis CEO Vas Narasimhan stated during a second-quarter earnings call that the company's recent China deals are driven by scientific merit rather than strategic acquisition for its own sake.

Importance:4/10
Sentiment:
0.00
earnings callChina strategyM&Ageographic expansion
Related Companies

Read the original article

Published by Endpoints News on July 21, 2026 3:41 PM

Read Original